| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a305f832ebc74c923043715dd06e42a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d12b35c0dd9adfb167b3b4f383afe93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa6cd5df0aa85e1c1a197a92de75d349
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa53071355359b54370d44fbd0993f74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a18a5134a72fc0f733536c750ecabfbd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate |
2019-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c27b2643348720f79b4708e0f4e2f84a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8568028746d0fc5a80cbd684dcccc2af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffe4f9088a11f9b7789703fa25479516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c599a44b6047ba33a7dd4c550192f5fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7837f1396b9101924f840a102c12eea9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d7577e542ea6118080a4fef5afa97bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21b1984c8d432cd72d8886fd97fe7422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2145d8ccb73bef0509974528330e3248
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a391db014eb1f6831a94c53fa6850eab |
| publicationDate |
2021-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3800195-A1 |
| titleOfInvention |
Peptide compounds for reducing side effects of cb1 receptor agonists |
| abstract |
The present invention relates to compounds of formula (I)n nor a pharmaceutically acceptable salts thereof, to processes for their obtention and to their therapeutic indications. |
| priorityDate |
2019-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |